Company / Return on Assets (ROA)
Caribou Biosciences, Inc. Return on Assets (ROA) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-84.5%
FY2025
5-year range
-84.5% / -5.3%
FY2021-FY2025
Trend
-159.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has declined for 4 consecutive years, from -5.3% in FY2021 to -84.5% in FY2025.
Based on SEC 10-K filings.
-84.5% in FY2025 with a 3-year CAGR of -66.6%.
Declined from -23.0% to -84.5% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -66.6pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- Caribou Biosciences, Inc.'s return on assets (roa) has declined for 4 consecutive years.
- In FY2025, return on assets (roa) decreased 159.3% year-over-year.
- Peak return on assets (roa) was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.99 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -84.5% | -159.3% |
| FY2024 | -32.6% | -41.7% |
| FY2023 | -23.0% | -28.4% |
| FY2022 | -17.9% | -237.9% |
| FY2021 | -5.3% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026